In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
Public ClinicalTrials.gov record NCT07218120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Trial of Financial Incentives for In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. The purpose of this study is to assess whether offering small $25 financial incentives can increase enrollment of diverse community members to the Alzheimer's Prevention Trial (APT) Webstudy, a memory concerns registry meant to accelerate clinical trials, relative to non-monetary incentives such as a reusable grocery bag. To do this we will test in-person recruitment efforts at community events and locations, such as Northgate Gonzalez Market locations and local food bank events. We also aim to compare the relative cost of recruiting an additional person to the APT Webstudy.
Study identification
- NCT ID
- NCT07218120
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 209 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 9, 2025 (Actual)
- Primary completion
- Oct 31, 2025 (Actual)
- Completion
- Oct 31, 2025 (Actual)
- Last update posted
- Sep 15, 2026
2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northgate Gonzalez Market | Chula Vista | California | 91919 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07218120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07218120 live on ClinicalTrials.gov.